PrognomiQ
Dr. Berkovitz serves on the Board of Directors for PrognomiQ. He is also Partner and CFO at aMoon Fund, a leading global HealthTech & Life Sciences venture capital fund, with over $1 billion under management. Prior to joining aMoon in 2018, he was COO and CFO for Alcobra, a NASDAQ-traded pharmaceutical company that merged with Arcturus Therapeutics. Prior to Alcobra, Mr. Berkovitz was at JP Morgan in their Investment Banking division in New York. He currently serves on the Board of several private healthcare companies. Mr. Berkovitz received his Ph.D. in Finance from Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PrognomiQ
1 followers
PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment.